Tumor-associated trypsin inhibitor

被引：0
|
作者：
Stenman, UH [1 ]
机构：
[1] Univ Helsinki, Cent Hosp, Dept Clin Chem, Biomedicum, FIN-00029 Helsinki, Finland
来源：
CLINICAL CHEMISTRY | 2002年 / 48卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Tumor-associated trypsin inhibitor (TATI) is a low-molecular-weight (6 kDa) trypsin inhibitor that has been used as a marker for ovarian cancer. It is also expressed together with tumor-associated trypsin by many other tumors, and increased serum concentrations of TATI occur in connection with these. TATI is a prognostic marker for ovarian, bladder, and kidney cancer, which may be associated with the participation of trypsin in protease cascades contributing to tumor invasiveness. (C) 2002 American Association for Clinical Chemistry.
引用
收藏
页码：1206 / 1209
页数：4
相关论文
共 50 条
  • [41] Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells
    V Gouyer
    D Fontaine
    P Dumont
    O de Wever
    H Fontayne-Devaud
    E Leteurtre
    S Truant
    D Delacour
    H Drobecq
    J-P Kerckaert
    Y de Launoit
    M Bracke
    C Gespach
    J-L Desseyn
    G Huet
    Oncogene, 2008, 27 : 4024 - 4033
  • [42] Cyst fluid tumor-associated trypsin inhibitor may be helpful in the differentiation of cystic pancreatic lesions
    Sari Räty
    Juhani Sand
    Henrik Alfthan
    Caj Haglund
    Isto Nordback
    Journal of Gastrointestinal Surgery, 2004, 8 : 569 - 574
  • [43] Tumor-associated trypsin inhibitor as a prognostic factor during follow-up of bladder cancer
    Kelloniemi, E
    Rintala, E
    Finne, P
    Stenman, UH
    UROLOGY, 2003, 62 (02) : 249 - 253
  • [44] Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells
    Gouyer, V.
    Fontaine, D.
    Dumont, P.
    de Wever, O.
    Fontayne-Devaud, H.
    Leteurtre, E.
    Truant, S.
    Delacour, D.
    Drobecq, H.
    Kerckaert, J-P
    de launoit, Y.
    Bracke, M.
    Gespach, C.
    Desseyn, J-L
    Huet, G.
    ONCOGENE, 2008, 27 (29) : 4024 - 4033
  • [45] Elevated serum inhibin and tumor-associated trypsin inhibitor concentrations in a young woman with dysgerminoma of the ovary
    Santala, M
    Burger, H
    Ruokonen, A
    Stenbäck, F
    Kauppila, A
    GYNECOLOGIC ONCOLOGY, 1998, 71 (03) : 465 - 468
  • [46] Cyst fluid tumor-associated trypsin inhibitor may be helpful in the differentiation of cystic pancreatic lesions
    Räty, S
    Sand, J
    Alfthan, H
    Haglund, C
    Nordback, I
    JOURNAL OF GASTROINTESTINAL SURGERY, 2004, 8 (05) : 569 - 574
  • [47] Tumor-associated trypsin inhibitor (TATI, PSTI, SPINK1) expression in prostate cancer is related to tumor grade
    Bjartell, A.
    Paju, A.
    Cao, Y.
    Laurila, T.
    Gadaleanu, V.
    Hotakainen, K.
    Stenman, U. H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (14) : 791 - 791
  • [48] The relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer
    Kemik, O.
    Kemik, A.
    Sumer, A.
    Almali, N.
    Gurluler, E.
    Gures, N.
    Purisa, S.
    Adas, G.
    Dogan, Y.
    Tuzun, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (21) : 2923 - 2928
  • [49] EFFECT OF INTRACAVITARY RADIOTHERAPY ON TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) IN PATIENTS WITH CERVICAL AND ENDOMETRIAL CANCER
    LEHTOVIRTA, P
    TURPEINEN, U
    STENMAN, UH
    GYNECOLOGIC ONCOLOGY, 1990, 38 (01) : 110 - 113
  • [50] PURIFICATION AND CHARACTERIZATION OF A TUMOR-ASSOCIATED TRYPSIN-INHIBITOR FROM THE URINE OF A PATIENT WITH OVARIAN-CANCER
    HUHTALA, ML
    PESONEN, K
    KALKKINEN, N
    STENMAN, UH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1982, 257 (22) : 13713 - 13716
12345